Skip to main content

Table 1 Patients’ characteristics

From: The relationship of Vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer

Variable Subgroup No. of patients %
Sex Male 125 65.8
  Female 65 34.2
Age Median 55 years  
  Range (24–79 years)  
ECOG performance status 0,1 186 97.9
  2 4 2.1
Lauren Intestinal 26 13.7
  Diffuse 41 21.6
  Mixed 18 9.5
  Unknown 105 55.3
Initial stage 1 8 4.2
  2 28 14.7
  3 41 21.6
  4 113 59.5
Operation + 127 66.8
  - 63 33.2
Adjuvant therapy + 79 41.6
  - 111 58.4
No. of metastasis 1 106 55.8
  2 54 28.4
  > 3 30 15.8
CEA < 5 ng/ml 119 62.6
  ≥ 5 ng/ml 54 28.4
  Unchecked 17 8.9
  1. ECOG: eastern cooperative oncology group, CEA: carcinoembryonic antigen.